Company intelligence / Profile preview

Hong Kong Institute of Biotechnology

Ownership: Private
Development stage: Other

Overview

HKIB provides infrastructure support, product and technology development services, contract manufacturing under GMP standards, and consultation/training for the biotechnology and Chinese medicine industries. It acts as a catalyst for research commercialization but does not itself develop clinical-stage therapeutics.

Modalities: BiologicChinese medicine (CM)Small molecule (inferred from biotech/pharma focus)
Industry: Contract Manufacturing Organization

Partnerships

Industrial partners for collaborative projects and fund applications

Beyond the preview

Go deeper on Hong Kong Institute of Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hong Kong Institute of Biotechnology.

Explore the full profile